Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50

50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险

基本信息

  • 批准号:
    8325331
  • 负责人:
  • 金额:
    $ 173.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-06 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The etiology of breast cancer in younger women (diagnosed < 50 years of age) is poorly understood and understudied. These cancers have a higher prevalence of more aggressive, hormone receptor negative tumors and are associated with poorer prognosis. The incidence rate among women through age 40 years is higher among Black vs. White women, but risk appears to be increasing among White women in the United States. Young Black women also have a higher prevalence of more aggressive, hormone receptor negative tumors. Recent evidence suggests this may also be true for women of lower socioeconomic status (SES). Potentially modifiable risk factors related to energy balance over the life course (e.g. growth patterns, pubertal maturation, adiposity, insulin resistance, diet and physical activity) have been implicated in the etiology of breast cancer in younger women. The objectives of this study are to investigate, in a socioeconomically diverse population of Black and White women, whether life course (in utero/perinatal, childhood, adolescent, and adult) energy balance factors, or polymorphic variation in candidate genes in energy balance pathways, are associated with breast cancer risk overall and by tumor subtype. Specific Aims: Among Black and White women < 50 years, we propose: 1) To investigate the association between adult energy balance factors-general (subcutaneous) adiposity, central (visceral) adiposity, serum adipokine biomarkers, an insulin resistance related diet pattern, and physical activity-with breast cancer risk; (2) To examine the association between early life energy balance factors-growth, adiposity, and onset of menses-with breast cancer risk; and (3) To study joint associations between life course energy balance factors-aforementioned adult and early life factors-with breast cancer risk. All associations will be studied, (a) by race (Black/White) and SES, (b) jointly with candidate genes in the energy balance pathway (based on function and genome wide association studies), and (c) for overall breast cancer and by tumor subtype (basal-like, HER2+/estrogen receptor (ER)-, Luminal A, and Luminal B). Methods: We propose to conduct a population-based case control study of 2,000 incident in situ and invasive breast cancer cases, diagnosed from 2011 to 2014, in Black (n=1,000) and White (n=1,000) women aged < 50 years residing in Metropolitan Detroit and Los Angeles County SEER areas, and a population-based sample of 2,000 control women frequency-matched on age, race and SEER area. We will collect anthropometric measurements, blood, photographs, questionnaire data on life course energy balance and other known risk factors, and tumor tissue. Significance: Our proposed study will, (1) provide insight into potentially modifiable risk factors for breast cancer in younger women, (2) examine risk factors for specific breast tumor subtypes, including the aggressive basal-like/'triple negative' tumors, (3) be the largest study of breast cancer in younger African American women, (4) have the ability to investigate the joint effect of race and SES, and (5) create a bio-repository of blood, tumor tissue microarrays and DNA for current and future study. PUBLIC HEALTH RELEVANCE Breast cancer (BC) in younger women has a greater prevalence of tumors with poor prognosis and is most common in African American women under 40 years of age. Little research has been conducted on causes of BC in young women, particularly by molecular tumor subtypes, but energy balance factors over the life course (growth patterns, onset of menses, body size, physical activity, diet and related genes) have been implicated. This project - the largest study to date of BC in young African American women - will integrate information over the life course to investigate these risk factors overall and by molecular tumor subtypes to lay the foundation for further research, identify populations at highest risk and determine opportunities for modifiable intervention and prevention.
描述(由申请人提供):年轻女性(诊断年龄< 50岁)乳腺癌的病因学知之甚少,研究不足。这些癌症具有更高的侵袭性、激素受体阴性肿瘤的患病率,并且与较差的预后相关。黑人女性40岁以下的发病率高于白色女性,但美国白色女性的风险似乎正在增加。年轻的黑人女性也有更高的发病率更积极的,激素受体阴性肿瘤。最近的证据表明,这可能也适用于社会经济地位较低的妇女。与生命过程中的能量平衡有关的潜在可改变的风险因素(例如生长模式、青春期成熟、肥胖、胰岛素抵抗、饮食和体力活动)与年轻女性乳腺癌的病因有关。本研究的目的是调查,在一个社会经济多样化的黑人和白色妇女的人口,是否生命过程(在子宫内/围产期,儿童,青少年和成人)能量平衡因素,或多态性变异的候选基因的能量平衡途径,与乳腺癌的风险整体和肿瘤亚型。具体目标:在< 50岁的黑人和白色女性中,我们提出:1)调查成人能量平衡因子之间的关联-一般(皮下)肥胖,中枢性(内脏)肥胖,血清脂肪因子生物标志物,胰岛素抵抗相关的饮食模式,和体力活动-与乳腺癌的风险;(2)研究生命早期能量平衡因素--生长、肥胖和月经开始--与乳腺癌风险之间的关系;(3)研究生命过程能量平衡因子(上述成人和早期生命因子)与乳腺癌风险之间的联合关系。将研究所有相关性,(a)按人种(黑人/白色)和SES,(B)与能量平衡途径中的候选基因(基于功能和全基因组关联研究),以及(c)总体乳腺癌和肿瘤亚型(基底样、HER 2 +/雌激素受体(ER)-、管腔A和管腔B)。研究方法:我们建议对2011年至2014年诊断的2,000例原位和浸润性乳腺癌病例进行一项基于人群的病例对照研究,这些病例来自居住在底特律大都会和洛杉矶县SEER地区的50岁以下黑人(n= 1,000)和白色(n=1,000)女性,以及2,000例年龄频率匹配的对照女性的基于人群的样本,种族和SEER地区。我们将收集人体测量数据、血液、照片、关于生命过程能量平衡和其他已知风险因素的问卷调查数据以及肿瘤组织。重要性:我们提出的研究将,(1)提供对年轻女性乳腺癌潜在可改变的风险因素的见解,(2)检查特定乳腺肿瘤亚型的风险因素,包括侵袭性基底样/“三阴性”肿瘤,(3)是年轻非洲裔美国女性乳腺癌的最大研究,(4)有能力调查种族和SES的联合影响,以及(5)创建血液、肿瘤组织微阵列和DNA的生物储存库,用于当前和未来的研究。 公共卫生相关性年轻女性中的乳腺癌(BC)具有更高的肿瘤患病率,预后不良,并且在40岁以下的非洲裔美国女性中最常见。关于年轻女性BC的原因,特别是分子肿瘤亚型的研究很少,但生命过程中的能量平衡因素(生长模式,月经开始,体型,体力活动,饮食和相关基因)已经被牵连。该项目是迄今为止在年轻的非洲裔美国妇女中进行的最大规模的BC研究,将整合整个生命过程中的信息,以调查这些风险因素,并通过分子肿瘤亚型为进一步研究奠定基础,确定最高风险人群,并确定可修改的干预和预防机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELLEN M VELIE其他文献

ELLEN M VELIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELLEN M VELIE', 18)}}的其他基金

Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    8122127
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    8548097
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    8726733
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    8839488
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    7890156
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
Life Course Energy Balance and Breast Cancer Risk in Black/White Women Under 50
50 岁以下黑人/白人女性的生命过程能量平衡和乳腺癌风险
  • 批准号:
    8913041
  • 财政年份:
    2010
  • 资助金额:
    $ 173.21万
  • 项目类别:
A Population Based Study of Birth Characteristics and Maternal Breast Cancer
出生特征和孕产妇乳腺癌的人群研究
  • 批准号:
    7482508
  • 财政年份:
    2007
  • 资助金额:
    $ 173.21万
  • 项目类别:
A Population Based Study of Birth Characteristics and Maternal Breast Cancer
出生特征和孕产妇乳腺癌的人群研究
  • 批准号:
    7261799
  • 财政年份:
    2007
  • 资助金额:
    $ 173.21万
  • 项目类别:
Race/Socioeconomic Area Characteristics & Cancer-Detroit
种族/社会经济区域特征
  • 批准号:
    6951834
  • 财政年份:
    2004
  • 资助金额:
    $ 173.21万
  • 项目类别:
Race/Socioeconomic Area Characteristics & Cancer-Detroit
种族/社会经济区域特征
  • 批准号:
    6889162
  • 财政年份:
    2004
  • 资助金额:
    $ 173.21万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
    Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 173.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了